ClinicalTrials.gg
Not yet recruitingNCT07922382Updated Nov 10, 2026

Integrated Attachment Theory

An interventional study of IAT in Attachment Disorder, sponsored by Boston University Charles River Campus. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Supportive care

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This pilot randomized waitlist-controlled study will evaluate the feasibility and preliminary effects of a 12-week Integrated Attachment Theory (IAT) psychoeducational coaching program in adults ages 18-65 with an insecure attachment pattern identified through study screening.

Eligible participants will be randomized 1:1 to immediate IAT or a 12-week waitlist followed by IAT. The immediate group will complete in-person Boston University assessments before and after IAT; the waitlist group will complete assessments at baseline, after the 12-week waiting period, and after subsequently completing IAT.

The primary objectives are to determine whether the study procedures and intervention are feasible and to estimate the magnitude and variability of pre/post changes. The investigators hypothesize that IAT will be associated with improvement in attachment-related patterns, emotion regulation, interpersonal functioning, and well-being, together with changes in physiological and cortical responses during attachment-related emotion regulation compared with the waitlist period.

02

Conditions studied

  • Attachment Disorder

Keywords

  • Integrated Attachment Theory (IAT)
  • Personal Development School
  • Interpersonal functioning
  • functional near-infrared spectroscopy (fNIRS)
03

In context

Lead sponsor

Boston University Charles River Campus is the lead sponsor of 159 studies on the registry; 33 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 9 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Speak and read English sufficiently to complete study questionnaires and the IAT program
  • Meets the PDS attachment-style eligibility criterion for insecure attachment
  • Able and willing to attend required in-person Boston University (BU) research visits
  • Able and willing, if assigned, to participate in the 12-week remote IAT program.

Exclusion criteria

Exclusion Criteria:

  • Self-reported neurological disorder or condition
  • Self-reported psychiatric/mental-health disorder
  • Patient Health Questionnaire-9 (PHQ-9) total score >14
  • Generalized Anxiety Disorder-7 (GAD-7) total score >14
  • Failure to meet the PDS attachment-style eligibility criterion
  • Inability to complete required study procedures
  • A safety concern that makes participation inappropriate.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Immediate Integrated Attachment Theory (IAT)

    Participants randomized to this arm will immediately receive the 12 week IAT intervention.

    Behavioral: IAT

  • Active comparator
    Waitlist followed by IAT

    Participants randomized to this arm will be put on a 12 week waitlist and after will receive the IAT intervention.

    Behavioral: IAT

Interventions

  • BehavioralIAT

    IAT provides12 consecutive weekly remote Zoom sessions delivered by Personal Development School (PDS). Each session lasts approximately 2.5 hours with about 90 minutes of teaching plus 1 hour of supervised support. Participants will work in small breakout rooms with two participants per room during the support portion. The 12-week curriculum addresses core beliefs, relationship needs, emotional/nervous-system patterns, communication, boundaries, and behaviors. Participants will also complete approximately 10 minutes of daily skills practice/homework.

06

What researchers measure

Primary outcomes

  1. Feasibility of IAT intervention

    Feasibility will be assessed using intervention and study completion. The number and percentage of participants assigned to IAT who complete the 12-week IAT program and the corresponding post-intervention research assessment will be calculated. Higher completion/retention rates will indicate greater feasibility.

    Time frame: baseline through 12 weeks

  2. Change in attachment

    Attachment will be assessed using the self-report Personal Development School (PDS) Attachment-Style Questionnaire administered at baseline and again at the post-intervention assessment. The questionnaire characterizes participants' attachment patterns, including secure and insecure attachment styles. Change from baseline to 12 weeks will be evaluated, with movement toward greater attachment security interpreted as improvement.

    Time frame: baseline and 12 weeks

Secondary outcomes

  1. Change in emotion regulation, measured by the Difficulties in Emotion Regulation Scale (DERS-36)

    Emotion regulation will be assessed using the 36-item self-report Difficulties in Emotion Regulation Scale (DERS-36). Items are rated on a 5-point scale from 1 (almost never) to 5 (almost always). The total score ranges from 36 to 180. Higher scores indicate greater difficulties with emotion regulation; therefore, a decrease in score from baseline indicates improvement in emotion regulation.

    Time frame: baseline and 12 weeks

  2. Change in interpersonal functioning, measured by the Inventory of Interpersonal Problems-32 (IIP-32)

    Interpersonal functioning will be assessed using the 32-item self-report Inventory of Interpersonal Problems, Short Form (IIP-32). Items are rated from 0 (not at all) to 4 (very much) and assess difficulties across eight interpersonal domains. Higher scores indicate greater interpersonal difficulties; therefore, a decrease from baseline indicates improvement in interpersonal functioning.

    Time frame: baseline and 12 weeks

  3. Change in well-being, measured by the WHO-5 Well-Being Index

    Well-being will be assessed using the 5-item self-report World Health Organization 5 (WHO-5) Well-Being Index. Each item is rated from 0 to 5. Raw scores range from 0 to 25 and are multiplied by 4 to yield a score from 0 to 100. Higher scores indicate better well-being; therefore, an increase from baseline indicates improvement.

    Time frame: baseline and 12 weeks

07

Study locations

1 site
  • Boston University Center for Life Science & Engineering
    Boston, Massachusetts 02215, United States
    • Meryem Yücel, PhD · Contactmayucel@bu.edu · 617-353-1181
    • Miray Altinkaynak, PhD MPH · Contact
08

Updates

2 registry updates since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 2 updates
  1. Nov 10, 2026
    Minor edits only
    + 2 other changes: identifiers and verification date
  2. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07922382
Collaborators
Personal Development School (PDS)
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Dec 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Meryem Yücel, PhD
Contact
mayucel@bu.edu
617-353-1181
Meryem Yücel, PhD
principal investigator · BU, Biomedical Engineering, Neurophotonics Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion